TrademarkDir
OBSIDIAN
LIVE

Serial Number

86897180

Owner

Obsidian Therapeutics, Inc.

Attorney

Olivia Maria Baratta

First Use Date

Dec 16, 2017

Filing Date

Feb 4, 2016

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

OBSIDIAN Trademark

Serial Number: 86897180 • Registration: 5408049

OBSIDIAN is a trademark filed by Obsidian Therapeutics, Inc. on February 4, 2016. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Obsidian Therapeutics, Inc. (24 trademarks)

1030 Massachusetts Avenue, Fourth Floor
Cambridge, MA 02138

Entity Type: 03

Trademark Details

Filing Date

February 4, 2016

Registration Date

February 20, 2018

First Use Anywhere

December 16, 2017

First Use in Commerce

December 16, 2017

Published for Opposition

June 28, 2016

Goods & Services

Pharmaceutical research and development in the field of gene therapy

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Oct 22, 2024 NURC
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sep 16, 2024 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 16, 2024 C15A
CORRECTION UNDER SECTION 7 - PROCESSED
Sep 16, 2024 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 9, 2024 APRE
TEAS SECTION 7 REQUEST RECEIVED
Feb 15, 2024 ES7R
TEAS SECTION 8 & 15 RECEIVED
Feb 14, 2024 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 20, 2023 REM1
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 6, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 6, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 6, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 6, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jul 6, 2022 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 18, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 18, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 18, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 18, 2021 REAP
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 9, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 9, 2019 REAP
REGISTERED-PRINCIPAL REGISTER
Feb 20, 2018 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 18, 2018 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 17, 2018 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jan 17, 2018 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jan 15, 2018 AITU
USE AMENDMENT FILED
Jan 2, 2018 IUAF
TEAS STATEMENT OF USE RECEIVED
Jan 2, 2018 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 18, 2017 EXRA
SOU EXTENSION 2 GRANTED
Aug 16, 2017 EX2G
SOU EXTENSION 2 FILED
Aug 16, 2017 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 16, 2017 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Aug 15, 2017 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Aug 15, 2017 COAR
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 15, 2017 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 15, 2017 COAR
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 16, 2017 EXRA
SOU EXTENSION 1 GRANTED
Feb 14, 2017 EX1G
SOU EXTENSION 1 FILED
Feb 14, 2017 EXT1
SOU TEAS EXTENSION RECEIVED
Feb 14, 2017 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 14, 2017 TCCA
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Aug 23, 2016 NOAM
CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Jun 28, 2016 CHPB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 28, 2016 NPUB
PUBLISHED FOR OPPOSITION
Jun 28, 2016 PUBO
ASSIGNED TO PETITION STAFF
Jun 13, 2016 APET
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 8, 2016 NONP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 2, 2016 TCCA
TEAS POST PUBLICATION AMENDMENT RECEIVED
Jun 2, 2016 EPPA
APPROVED FOR PUB - PRINCIPAL REGISTER
May 22, 2016 CNSA
ASSIGNED TO EXAMINER
May 20, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 9, 2016 NWOS
NEW APPLICATION ENTERED
Feb 8, 2016 NWAP

Related Trademarks

More from this Owner

CYTOTIL15

CYTOTIL15

CYTOTIL15

CYTOTIL15

OBSIDIAN

OBSIDIAN

OBSIDIAN THERAPEUTICS

OBSIDIAN THERAPEUTICS

OBSIDIAN

OBSIDIAN

OBSIDIAN THERAPEUTICS

OBSIDIAN THERAPEUTICS